0
days
0
hours
0
min.
0
sec.

💥 Stay Ahead This Earnings Season
Save 15% on Annual Plans

0
days
0
hours
0
min.
0
sec.
Shop the Plans →
Stock Reviews

4 SaaS Stocks Analysts Expect to Rebound Up to 60%

Roxanna Maglangit
Roxanna Maglangit5 minute read
Reviewed by: Thomas Richmond
Last updated Oct 14, 2025

After several years of multiple compression, many SaaS stocks now trade at more reasonable valuations despite steady revenue growth and improving profitability.

Investors have become more selective, rewarding companies with durable business models and recurring cash flow.

Here are 4 SaaS stocks analysts expect could rebound meaningfully, with upside potential of up to 60% over the next year.

Company Name (Ticker)NTM EV/RevenueAnalyst Upside
Definitive Healthcare (DH)1.7x58%
Sprinklr (CXM)1.7x44%
8×8 (EGHT)6.6x38%
ZoomInfo Technologies (GTM)3.8x17%
SaaS Stocks (TIKR)

Unlock our Free Report: 5 undervalued compounders with upside based on Wall Street’s growth estimates that could deliver market-beating returns (Sign up for TIKR, it’s free) >>>

Definitive Healthcare (DH)

Definitive Healthcare Target Price (TIKR)

Definitive Healthcare (DH) is a software and data analytics company that provides commercial intelligence on healthcare providers, physicians, and organizations. Its platform is used by life sciences companies, healthcare IT vendors, and providers to support go-to-market strategies and operational planning.

Historically, the company delivered strong revenue growth, but over the last twelve months (ending Q2 2025), its revenue growth has turned negative, at approximately -5.24%, reflecting current macroeconomic pressures. Definitive Healthcare does not currently pay a dividend, as cash flow is directed toward product development and customer acquisition. The company’s recurring revenue model and a focus on maintaining strong profitability (e.g., Adjusted EBITDA margin remains over 30%) position it for potential stabilization and future expansion in the healthcare analytics market.

Value stocks like Definitive Healthcare in under 60 seconds with TIKR’s new Valuation Model (It’s free) >>>

Sprinklr (CXM)

Sprinklr Target Price (TIKR)

Sprinklr (CXM) is a customer experience management software provider that offers a unified platform for social media management, marketing, analytics, and customer service. Its solutions are used by large enterprises across industries to manage customer interactions and brand presence across digital channels.

The company has reported strong historical revenue growth, though recent total revenue growth has moderated to ≈6−9% annually (e.g., 9% for Fiscal Year 2025), supported by rising demand for omnichannel customer engagement tools. Its recent Return on Equity (ROE) has significantly improved, standing at approximately 21-24% (Trailing Twelve Months as of late 2025), reflecting increased profitability and efficient use of shareholder equity.

With a growing recurring revenue base and increasing operating leverage, the company continues to build its presence in the customer experience software market.

Track Sprinklr’s financials, growth trends, and analyst forecasts on TIKR (it’s free)>>>

8×8 (EGHT)

8×8 Price Target (TIKR)

8×8 (EGHT) is a communications-as-a-service provider specializing in cloud-based voice, video, chat, and contact center solutions for businesses, offering a platform that integrates unified communications and customer engagement tools.

Over the last five years, 8×8’s average annual revenue per share growth was approximately 6.1%, though recent total revenue has shown a slight decline (e.g., a 2% decrease in Fiscal Year 2025). The company’s focus on non-GAAP profitability has improved, but its 3-year average GAAP return on equity (ROE) remains significantly negative (e.g., around −18% to −22% over the last three fiscal years), reflecting ongoing restructuring costs and GAAP operating losses despite achieving GAAP operating profitability in its most recent fiscal year (FY2025).

8×8 does not pay dividends, prioritizing aggressive debt reduction (reducing principal debt by a significant amount) and reinvestment to strengthen its financial position and drive its shift toward higher-margin enterprise and Contact Center as a Service (CCaaS) offerings.

See if top investors & hedge funds are buying or selling 8×8 right now (It’s free) >>>

Wall Street Analysts Are Bullish on These 5 Undervalued Compounders With Market-Beating Potential

TIKR just released a new free report on 5 compounders that appear undervalued, have beaten the market in the past, and could continue to outperform on a 1-5 year timeline based on analysts’ estimates.

Inside, you’ll get a breakdown of 5 high-quality businesses with:

  • Strong revenue growth and durable competitive advantages
  • Attractive valuations based on forward earnings and expected earnings growth
  • Long-term upside potential backed by analyst forecasts and TIKR’s valuation models

These are the kinds of stocks that can deliver massive long-term returns, especially if you catch them while they’re still trading at a discount.

Whether you’re a long-term investor or just looking for great businesses trading below fair value, this report will help you zero in on high-upside opportunities.

Click here to sign up for TIKR and get our full report on 5 undervalued compounders completely free.

Looking for New Opportunities?

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!

Related Posts

Stock Reviews
9 minute read

Why Babcock Could Be the Quiet Winner of the Global Defence Boom

Babcock’s turnaround story is gathering momentum. Stronger margins, a cleaner balance sheet, and an upgraded medium-term outlook signal that the defence contractor is finally converting years of restructuring into real cash and shareholder returns.
David Beren
David BerenOct 14, 2025
Stock Reviews
9 minute read

Greggs Stock Falls, But Its Growth Strategy Is Just Getting Started

Greggs’ latest results show short-term cost pressure but long-term potential. With new capacity, technology, and formats on the way, 2025 may mark a turning point rather than a step back.
David Beren
David BerenOct 14, 2025
Stock Reviews
7 minute read

8 Companies Generating 25%+ Free Cash Flow Margins

Here are 8 companies generating free cash flow margins above 25%, highlighting businesses with strong profitability, efficient operations, and the ability to turn revenue into lasting shareholder value.
Roxanna Maglangit
Roxanna MaglangitOct 14, 2025
Stock Reviews
9 minute read

Can HSBC Holdings Balance Growth and Risk in a Volatile Global Market?

HSBC’s restructuring is showing results, but the gains are uneven. The bank continues to grow its wealth and markets businesses, even as impairments and one-time losses weigh on profits.
David Beren
David BerenOct 14, 2025
Stock Reviews
9 minute read

Will GSK’s Specialty Medicines Keep Its Growth Engine Running?

GSK’s transformation into a pure-play biopharma company continues to show steady progress. Specialty Medicines and Vaccines are now driving the majority of sales and profits, even as the company contends with a sharp drop in net income and margin pressure.
David Beren
David BerenOct 14, 2025

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required